Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WATSON LABS

  • FDA Approval
  • March 05, 2024, 10:11 UTC
  • 42
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

WATSON LABS

  • FDA Approval
  • March 05, 2024, 10:11 UTC
  • 47
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

CARNEGIE

  • FDA Approval
  • March 05, 2024, 05:40 UTC
  • 49
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • March 05, 2024, 05:40 UTC
  • 45
  • 0 comments

FDA approve DOCOSANOL

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • March 04, 2024, 13:10 UTC
  • 49
  • 0 comments

FDA approve SCOPOLAMINE

Comment Full text

MYLAN SPECIALITY LP

  • FDA Approval
  • March 04, 2024, 12:52 UTC
  • 46
  • 0 comments

FDA approve HYDROCORTISONE ACETATE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve NADOLOL

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 42
  • 0 comments

FDA approve DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE

Comment Full text

DEXCEL LTD

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 42
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 39
  • 0 comments

FDA approve ALCAFTADINE

Comment Full text
  • Previous
  • 536
  • 537
  • 538
  • 539
  • 540
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183571)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin